Relmada Therapeutics
RLMD
RLMD
79 hedge funds and large institutions have $40.7M invested in Relmada Therapeutics in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 31 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
52% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 31
68% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 19
Holders
79
Holding in Top 10
–
Calls
$568K
Puts
$201K
Top Buyers
| 1 | +$1.15M | |
| 2 | +$712K | |
| 3 | +$530K | |
| 4 |
Renaissance Technologies
New York
|
+$161K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$150K |
Top Sellers
| 1 | -$831K | |
| 2 | -$550K | |
| 3 | -$477K | |
| 4 |
Jane Street
New York
|
-$413K |
| 5 |
GIM
Guild Investment Management
Los Angeles,
California
|
-$352K |